Celldex's Varlilumab Demonstrates Synergistic Anti-Tumor Activity with PD-1 Signaling Blockade in Preclinical Studies
April 20, 2015 at 08:02 AM EDT
Celldex Therapeutics, Inc. (Nasdaq: CLDX) announced today preclinical results that further support varlilumab's expansion into ...